N-benzyl-N-methyldecan-1-amine, a phenylamine derivative isolated from garlic cloves, induces G2/M phase arrest and apoptosis in U937 human leukemia cells

Oncology Reports

Volumn 32, Issue 1, 2014, Pages 373-381

  Jeong, Jin Woo ^a   Park, Sejin ^b   Park, Cheol ^c   Chang, Young Chae ^d   Moon, Dong O H ^e   Kim, Sung O K ^e,f   Kim, G I Young ^g   Cha, Hee Jae ^h   Kim, Heui Soo ^b   Choi, Young Whan ^b   Kim, Wun Jae ⁱ   Yoo, Young Hyun ^j   Choi, Yung Hyun ^c,k  

^a Daegu Gyeongbuk Institute of Science and Technology   (South Korea)

^b Pusan National University   (South Korea)

^c Dong Eui University   (South Korea)

^d Catholic University of Daegu   (South Korea)

^e Daegu University   (South Korea)

^f Daegu Haany University   (South Korea)

^g Jeju National University   (South Korea)

^h Kosin University College of Medicine   (South Korea)

ⁱ Chungbuk National University College of Medicine   (South Korea)

^j Dong A University College of Medicine   (South Korea)

^k Dong Eui University   (South Korea)

more..

Author keywords

Apoptosis; G2 M arrest; Leukemia U937 cells; N benzyl N methyldecan 1 amine

Indexed keywords

ANILINE DERIVATIVE; CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYTOCHROME C; INHIBITOR OF APOPTOSIS PROTEIN 1; N BENZYL N METHYLDECAN 1 AMINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN P53; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; ANTINEOPLASTIC AGENT; BENZYLAMINE DERIVATIVE; N-METHYLBENZYLAMINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; G2 PHASE CELL CYCLE CHECKPOINT; GENE REPRESSION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN SECRETION; U937 CELL LINE; WESTERN BLOTTING; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; GARLIC; GENE EXPRESSION REGULATION; LEUKEMIA; PATHOLOGY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZYLAMINES; CELL PROLIFERATION; G2 PHASE CELL CYCLE CHECKPOINTS; GARLIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA; MEMBRANE POTENTIAL, MITOCHONDRIAL; SIGNAL TRANSDUCTION; U937 CELLS;

EID: 84903198403     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3215     Document Type: Article

References (35)

1. Tsubura A, Lai YC, Kuwata M, Uehara N and Yoshizawa K: Anticancer effects of garlic and garlic-derived compounds for breast cancer control. Anticancer Agents Med Chem 11: 249-253, 2011.
2. Bianchini F and Vainio H: Allium vegetables and organosulfur compounds: do they help prevent cancer? Environ Health Perspect 109: 893-902, 2001. (Pubitemid 32976253)
3. Milner JA: Mechanisms by which garlic and allyl sulfur compounds suppress carcinogen bioactivation. Garlic and carcinogenesis. Adv Exp Med Biol 492: 69-81, 2001.
4. Kim JY and Kwon O: Garlic intake and cancer risk: an analysis using the Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims. Am J Clin Nutr 89: 257-264, 2009.
5. Fleischauer AT and Arab L: Garlic and cancer: a critical review of the epidemiologic literature. J Nutr 131: S1032-S1040, 2001.
6. Ngo SN, Williams DB, Cobiac L and Head RJ: Does garlic reduce risk of colorectal cancer? A systematic review. J Nutr 137: 2264-2269, 2007. (Pubitemid 47529588)
7. Sperka T, Wang J and Rudolph KL: DNA damage checkpoints in stem cells, ageing and cancer. Nat Rev Mol Cell Biol 13: 579-590, 2012.
8. Canavese M, Santo L and Raje N: Cyclin dependent kinases in cancer: potential for therapeutic intervention. Cancer Biol Ther 13: 451-457, 2012.
9. Modem S, Dicarlo SE and Reddy TR: Fresh garlic extract induces growth arrest and morphological differentiation of MCF7 breast cancer cells. Genes Cancer 3: 177-186, 2012.
10. Lund T, Stokke T, Olsen ØE and Fodstad Ø: Garlic arrests MDA-MB-435 cancer cells in mitosis, phosphorylates the proapoptotic BH3-only protein BimEL and induces apoptosis. Br J Cancer 92: 1773-1781, 2005. (Pubitemid 40756491)
11. Frantz DJ, Hughes BG, Nelson DR, Murray BK and Christensen MJ: Cell cycle arrest and differential gene expression in HT-29 cells exposed to an aqueous garlic extract. Nutr Cancer 38: 255-264, 2000. (Pubitemid 32762026)
12. Su CC, Chen GW, Tan TW, Lin JG and Chung JG: Crude extract of garlic induced caspase-3 gene expression leading to apoptosis in human colon cancer cells. In Vivo 20: 85-90, 2006.
13. Kim HJ, Han MH, Kim GY, Choi YW and Choi YH: Hexane extracts of garlic cloves induce apoptosis through the generation of reactive oxygen species in Hep3B human hepatocarcinoma cells. Oncol Rep 28: 1757-1763, 2012.
14. Na HK, Kim EH, Choi MA, Park JM, Kim DH and Surh YJ: Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1. Biochem Pharmacol 84: 1241-1250, 2012.
15. Xiao D, Herman-Antosiewicz A, Antosiewicz J, Xiao H, Brisson M, Lazo JS and Singh SV: Diallyl trisulfide-induced G(2)-M phase cell cycle arrest in human prostate cancer cells is caused by reactive oxygen species-dependent destruction and hyperphosphorylation of Cdc 25C. Oncogene 24: 6256-6268, 2005. (Pubitemid 43080049)
16. Di X, Andrews DM, Tucker CJ, Yu L, Moore AB, Zheng X, Castro L, Hermon T, Xiao H and Dixon D: A high concentration of genistein down-regulates activin A, Smad3 and other TGF-β pathway genes in human uterine leiomyoma cells. Exp Mol Med 44: 281-292, 2012.
17. Medema RH and Macůrek L: Checkpoint control and cancer. Oncogene 31: 2601-2613, 2012.
18. Rozenblat S, Grossman S, Bergman M, Gottlieb H, Cohen Y and Dovrat S: Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines. Biochem Pharmacol 75: 369-382, 2008. (Pubitemid 350298461)
19. Lim S and Kaldis P: Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development 140: 3079-3093, 2013.
20. Sánchez I and Dynlacht BD: New insights into cyclins, CDKs, and cell cycle control. Semin Cell Dev Biol 16: 311-321, 2005.
21. Jeong AL and Yang Y: PP2A function toward mitotic kinases and substrates during the cell cycle. BMB Rep 46: 289-294, 2013.
22. Lindqvist A, Rodríguez-Bravo V and Medema RH: The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J Cell Biol 185: 193-202, 2009.
23. Porter LA and Donoghue DJ: Cyclin B1 and CDK1: nuclear localization and upstream regulators. Prog Cell Cycle Res 5: 335-347, 2003.
24. Abbas T and Dutta A: p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400-414, 2009.
25. Brown L, Boswell S, Raj L and Lee SW: Transcriptional targets of p53 that regulate cellular proliferation. Crit Rev Eukaryot Gene Expr 17: 73-85, 2007. (Pubitemid 46511616)
26. Danova M, Giordano M, Mazzini G and Riccardi A: Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia. Leuk Res 14: 417-422, 1990. (Pubitemid 20175210)
27. Burz C, Berindan-Neagoe I, Balacescu O and Irimie A: Apoptosis in cancer: key molecular signaling pathways and therapy targets. Acta Oncol 48: 811-821, 2009.
28. Fulda S and Debatin KM: Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25: 4798-4811, 2006. (Pubitemid 44187627)
29. Liu Y, Bertram CC, Shi Q and Zinkel SS: Proapoptotic Bid mediates the Atr-directed DNA damage response to replicative stress. Cell Death Differ 18: 841-852, 2011.
30. Shamas-Din A, Brahmbhatt H, Leber B and Andrews DW: BH3-only proteins: Orchestrators of apoptosis. Biochim Biophys Acta 1813: 508-520, 2011.
31. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM: Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801-809, 1995.
32. Low IC, Kang J and Pervaiz S: Bcl-2: a prime regulator of mitochondrial redox metabolism in cancer cells. Antioxid Redox Signal 15: 2975-2987, 2011.
33. Galluzzi L, Larochette N, Zamzami N and Kroemer G: Mitochondria as therapeutic targets for cancer chemotherapy. Oncogene 25: 4812-4830, 2006. (Pubitemid 44192089)
34. LaCasse EC, Mahoney DJ, Cheung HH, Plenchette S, Baird S and Korneluk RG: IAP-targeted therapies for cancer. Oncogene 27: 6252-6275, 2008.
35. Hunter AM, LaCasse EC and Korneluk RG: The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12: 1543-1568, 2007. (Pubitemid 47106887)